Physician profile
Caitlin Bump
NPI 1760774376
$2,662.20
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,480 · 2020: $183.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,910.38 | 2019 | |
| Abbvie INC. | $151.55 | 2019-2020 | |
| Astellas Pharma US INC | $123.71 | 2019-2020 | |
| Minerva Surgical, INC | $81.66 | 2019-2020 | |
| Novo Nordisk INC | $73.05 | 2019 | |
| Amgen INC. | $70.00 | 2019-2020 | |
| Therapeuticsmd, INC. | $50.39 | 2019 | |
| Merck Sharp & Dohme LLC | $43.80 | 2019-2020 | |
| Covidien LP | $39.96 | 2019 | |
| Hologic Sales and Service, LLC | $31.41 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $26.27 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.18 | 2019 | |
| Becton, Dickinson and Company | $14.27 | 2019 | |
| Pfizer INC. | $12.65 | 2019 | |
| Mission Pharmacal Company | $11.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Bump listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.